Hebbian Bio is advancing NeuroType - a precision molecular engine that enables patient selection and target/biomarker discovery for neurodevelopmental and psychiatric disorders, initially focused on genetically validated forms of autism. We are building the molecular data engine to get to an individual's exact NeuroType in days not years, for better/new targeted therapeutics, and better patient segmentation for trials. We have partnered with patient organizations and are seeking investment and partnerships to scale NeuroType.